Excipient Market Overview: Evonik launches high-purity excipients; India mandates disclosures from March 2026

Data Compilation
#PharmaFlow

Pipeline Prospector November 2025: Kimberly-Clark to buy Kenvue for US$ 48.7 bn; FDA approves Novartis’ gene therapy

Stock Recap
#PipelineProspector

Docetaxel, anhydrous

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

95 API Suppliers, 40 USDMF, 29 CEP/COS, 10 JDMF, 11 EU WC, 16 KDMF, 15 NDC API, 42 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

544 Drugs in Development

544 Drugs in Development

INTERMEDIATES

9 Intermediate Suppliers

9 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

379 FDF Dossiers, 87 FDA Orange Book, 174 Europe, 4 Canada, 8 Australia, 34 South Africa, 72 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

INJECTABLE;INJECTION - 160MG/8ML (20MG/ML), INJECTABLE;INJECTION - 20MG/ML (20MG/ML), INJECTABLE;INJECTION - 20MG/0.5ML (40MG/ML), INJECTABLE;INJECTION - 80MG/4ML (20MG/ML), INJECTABLE;INJECTION - 80MG/2ML (40MG/ML), INJECTABLE;INJECTION - 160MG/8ML (20MG/ML), INJECTABLE;INJECTION - 20MG/ML (20MG/ML), INJECTABLE;INJECTION - 40MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, INJECTABLE;INJECTION - 80MG/4ML (20MG/ML), INJECTABLE;INJECTION - 160MG/8ML (20MG/ML), INJECTABLE;INJECTION - 20MG/ML (20MG/ML), INJECTABLE;INJECTION - 80MG/4ML (20MG/ML), INJECTABLE;INJECTION - 20MG/VIAL, INJECTABLE;INJECTION - 80MG/VIAL

RELATED EXCIPIENT COMPANIES

1 Boai NKY Pharmaceuticals Ltd, 3 Nanjing Well Pharmaceutical, 3 Kirsch Pharma, 2 Actylis, 2 BASF, 1 CD Formulation, 1 Clariant, 1 Finar, 3 Gangwal Chemicals, 1 Nanjing Bold Chemical, 6 Seppic, 1 Valens Pharmachem

EXCIPIENTS BY APPLICATIONS

13 Solubilizers, 10 Parenteral, 7 Thickeners and Stabilizers, 7 Topical, 4 Surfactant & Foaming Agents, 4 Emulsifying Agents, 4 Film Formers & Plasticizers, 2 Rheology Modifiers, 1 Direct Compression, 1 Taste Masking, 1 Coating Systems & Additives, 1 API Stability Enhancers, 1 Co-Processed Excipients

DIGITAL CONTENT

1 Data Compilation #PharmaFlow, 1 Stock Recap #PipelineProspector, 144 News #PharmaBuzz

GLOBAL SALES INFORMATION

14 US Medicaid Prescriptions, 42 Regulatory FDF Prices, 7 Annual Reports

MARKET PLACE

15 APIs, 14 FDF Dossiers

PATENTS & EXCLUSIVITIES

44 US Patents, 8 Health Canada Patents

REF. STANDARDS & IMPURITIES

4 EDQM, 2 USP, 4 JP, 18 Others

$ Xls download

Filters

Last Updated on PharmaCompass	Virtual Booth	Country	Registrant Name	Registration No.	Compound	Registration Date	Manufacturer	Manufacturer's Country	Manufacturer's Address
29/11/2025	Phyton Biotech LLC	Canada	Sampoong Pharmachem Co., Ltd.	20200421-210-J-608	Docetaxel	2020-04-21	Phyton Biotech LLC	Canada	1527 Cliveden Avenue, Delta, British Columbia, V3M6P7, Canada
29/11/2025	Fresenius Kabi AB Brunna	Sweden	Aging Life Science Co., Ltd.	20220829-210-J-1352	Docetaxel anhydrous	2022-08-29	Fresenius Kabi Oncology Limited	India	D-35, Industrial Area, Kalyani, Nadia-741 235 West Bengal, India

Docetaxel, Anhydrous

Docetaxel, anhydrous

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

95 API Suppliers

40 USDMF

29 CEP/COS

10 JDMF

11 EU WC

16 KDMF

15 NDC API

42 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

544 Drugs in Development

INTERMEDIATES

9 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

379 FDF Dossiers

87 FDA Orange Book

174 Europe

4 Canada

8 Australia

34 South Africa

72 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

INJECTABLE;INJECTION - 160MG/8ML (20MG/ML)

INJECTABLE;INJECTION - 20MG/ML (20MG/ML)

INJECTABLE;INJECTION - 20MG/0.5ML (40MG/ML)

INJECTABLE;INJECTION - 80MG/4ML (20MG/ML)

INJECTABLE;INJECTION - 80MG/2ML (40MG/ML)

INJECTABLE;INJECTION - 160MG/8ML (20MG/ML)

INJECTABLE;INJECTION - 20MG/ML (20MG/ML)

INJECTABLE;INJECTION - 40MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

INJECTABLE;INJECTION - 80MG/4ML (20MG/ML)

INJECTABLE;INJECTION - 160MG/8ML (20MG/ML)

INJECTABLE;INJECTION - 20MG/ML (20MG/ML)

INJECTABLE;INJECTION - 80MG/4ML (20MG/ML)

INJECTABLE;INJECTION - 20MG/VIAL

INJECTABLE;INJECTION - 80MG/VIAL

RELATED EXCIPIENT COMPANIES

1 Boai NKY Pharmaceuticals Ltd

3 Nanjing Well Pharmaceutical

3 Kirsch Pharma

2 Actylis

2 BASF

1 CD Formulation

1 Clariant

1 Finar

3 Gangwal Chemicals

1 Nanjing Bold Chemical

6 Seppic

1 Valens Pharmachem

EXCIPIENTS BY APPLICATIONS

13 Solubilizers

10 Parenteral

7 Thickeners and Stabilizers

7 Topical

4 Surfactant & Foaming Agents

4 Emulsifying Agents

4 Film Formers & Plasticizers

2 Rheology Modifiers

1 Direct Compression

1 Taste Masking

1 Coating Systems & Additives

1 API Stability Enhancers

1 Co-Processed Excipients

DIGITAL CONTENT

1 Data Compilation #PharmaFlow

1 Stock Recap #PipelineProspector

144 News #PharmaBuzz

GLOBAL SALES INFORMATION

14 US Medicaid Prescriptions

42 Regulatory FDF Prices

7 Annual Reports

MARKET PLACE

15 APIs

INJECTABLE;INJECTION - 40MG/ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons